Academic Item Menu


Biotechnology innovation is in a large part driven by the requirement for improvements in medical diagnosis and therapy for a range of diseases including autoimmune diseases, diseases of inflammation and cancer, and infectious diseases. Innovations in biomolecular therapies such as recombinant proteins, monoclonal antibodies, stem cells and novel bioinspired materials have and will continue to improve available medical treatments for many conditions. The course is designed to give students a detailed insight into the principles and techniques leading to these innovations. The practical work includes production of a recombinant monoclonal antibody fragment, and pre-clinical assessment of its diagnostic and therapeutic potential.

Study Level


Offering Terms

Term 3



Delivery Mode

Fully on-site

Indicative contact hours


Conditions for Enrolment

Course Outline

To access course outline, please visit:


Pre-2019 Handbook Editions

Access past handbook editions (2018 and prior)

Helpful utilities like sharing or printing this page
Share Link via Email
Download PDF